ScripWho: Eli Lilly/Juvena Therapeutics What: Juvena will use its AI platform JuvNET to identify stem cell-secreted protein drug candidates to help patients on obesity therapy maintain muscle mass and f
ScripSanofi’s plans for rilzabrutinib continue apace with positive mid-stage data in IgG4-related disease ahead of a potential US approval in the summer for the potential ‘pipeline-in-a-product’ in immune
Generics BulletinAmgen is trying to gain traction for its Pavblu (aflibercept-ayyh) biosimilar purely by offering better financial incentives, according to Eylea (aflibercept) originator Regeneron, which is continuing
In Vivo“The legend goes, I was about three years old, and I used to go around the house saying, ‘I’m going to be an eye doctor’,” Namrata Saroj recounts with a smile. This early declaration shaped her entire